Bristol-Myers Squibb Company
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists

Abstract:

The present invention provides compounds of Formula (I): ##STR00001## or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.